Get started

AVP

SHORT TERM PUMP?avp + avwap + frvp + pivot are all supporting bullish bias. short term pump incoming?? ++++++++++++++ avp + avwap + frvp + pivot are all supporting bullish bias. short term pump incoming??avp + avwap + frvp + pivot are all supporting bullish bias. short term pump incoming??avp + avwap + frvp + pivot are all supporting bullish bias. short term pump incoming??avp + avwap + frvp + pivot are all supporting bullish bias. short term pump incoming??avp + avwap + frvp + pivot are all supporting bullish bias. short term pump incoming??avp + avwap + frvp + pivot are all supporting bullish bias. short term pump incoming??avp + avwap + frvp + pivot are all supporting bullish bias. short term pump incoming??avp + avwap + frvp + pivot are all supporting bullish bias. short term pump incoming??avp + avwap + frvp + pivot are all supporting bullish bias. short term pump incoming??avp + avwap + frvp + pivot are all supporting bullish bias. short term pump incoming??avp + avwap + frvp + pivot are all supporting bullish bias. short term pump incoming??avp + avwap + frvp + pivot are all supporting bullish bias. short term pump incoming??avp + avwap + frvp + pivot are all supporting bullish bias. short term pump incoming??avp + avwap + frvp + pivot are all supporting bullish bias. short term pump incoming??avp + avwap + frvp + pivot are all supporting bullish bias. short term pump incoming??
Long
by reventioaxie
Apple Settles Trade Secrets Lawsuit Against Chip Startup RivosThe Settlement: In a recent development, tech giant Apple (NASDAQ: NASDAQ:AAPL ) has reached a settlement in its lawsuit against startup Rivos, accused of misappropriating trade secrets in the realm of computer-chip technology. The joint court filing, submitted in California federal court, indicates a significant step towards resolving the contentious legal battle. Implications for Tech Innovation: The resolution of this lawsuit holds profound implications for the tech industry, particularly in the domain of chip design and intellectual property protection. Apple's aggressive pursuit of legal action underscores the high stakes involved in safeguarding proprietary technologies amidst fierce competition and rapid technological advancements. The Allegations and Denials: Apple's initial lawsuit alleged that Rivos, a secretive startup, illicitly acquired confidential information and talent from Apple ( NASDAQ:AAPL ), leveraging these assets to develop competing System-on-Chip (SoC) technology. Rivos vehemently denied these accusations, asserting that Apple's actions were driven by a desire to stifle competition and thwart innovation. Balancing Innovation and Protection: The legal clash between Apple ( NASDAQ:AAPL ) and Rivos underscores the delicate balance between fostering innovation and protecting intellectual property rights. As companies strive to push the boundaries of technological advancement, disputes over trade secrets and employee mobility are increasingly common, necessitating robust legal frameworks and vigilant enforcement mechanisms. Apple's Vision for Spatial Computing: Amidst the legal wrangling, Apple ( NASDAQ:AAPL ) continues to advance its vision for spatial computing with the introduction of the Apple Vision Pro (AVP). Positioned as a versatile device catering to both consumer and enterprise markets, the AVP represents a significant foray into augmented reality (AR) and mixed reality (MR) technologies. Transforming Business Paradigms: With its emphasis on spatial computing, Apple aims to revolutionize various facets of enterprise operations, ranging from productivity and collaboration to immersive training experiences. By partnering with leading organizations across diverse industries, Apple ( NASDAQ:AAPL ) seeks to establish the AVP as a transformative platform driving innovation and enhancing user experiences. The Future of AR in Business: While the adoption of AR technologies in business has been gradual, the introduction of the AVP holds promise for accelerating this trend. By offering a seamless integration of familiar applications and novel spatial computing capabilities, Apple ( NASDAQ:AAPL ) seeks to catalyze the mainstream adoption of AR devices in enterprise settings. Opportunities and Challenges Ahead: As businesses explore the potential applications of the AVP, they must navigate a landscape characterized by both opportunities and challenges. While the device promises enhanced productivity and immersive experiences, concerns regarding content creation and data security remain pertinent, necessitating careful consideration and strategic planning. Conclusion In conclusion, the resolution of Apple's ( NASDAQ:AAPL ) lawsuit against Rivos marks a significant milestone in the ongoing evolution of the tech industry, underscoring the critical importance of protecting intellectual property rights while fostering innovation. With the introduction of the Apple Vision Pro, Apple ( NASDAQ:AAPL ) is poised to redefine the boundaries of spatial computing, offering new possibilities for businesses and consumers alike. As the AR landscape continues to evolve, embracing the transformative potential of devices like the AVP presents both opportunities and challenges for enterprises seeking to stay ahead in an increasingly digital world.
NASDAQ:AAPLLong
by DEXWireNews
DSKX Major Acquisition(NASDAQ: DSKX) – Research Report Company Name: DS Healthcare Group Inc. Stock Symbol: DSKX Company Website: www.dslaboratories.com Trading at $1.53 Per Share (02/16/2016) Currently DSKX has a very attractive valuation with high analyst ratings, hedge fund interest, strengthened management team and major upcoming catalyst. DSKX is trading at a 33M market cap while they are expected to close on a major acquisition which is expected to increase the company’s annual revenues to approximately $65 million and $10 million in EBITDA with the combined businesses from over 20 countries, 900 unique and diversified products, and a broad range of personal care categories. This acquisition fiercely scales up and expands DS Healthcare’s business operations, product portfolio and distribution network in one deal. With the deal in place, DSKX is trading well below 1x expected annual sales while in the recent years many of its competitors in the industry sold at approximately 5x sales. Nioxin, Chattem, Simple Health & Beauty just to name a few. Several weeks ago, Frigate Ventures LP filed a SC 13G. In the filing, it appears Frigate Ventures LP owns 1,500,000 shares of DSKX. This shows Frigate Ventures Lp’s confidence and optimism in the future of the company and as a institutional investor with an excellent track record, its safe to assume they do their homework before buying a 7.1% stake in a company. Read the full research report using this link www.stockpicksnyc.com
DLong
by StockPicksNYC